Summary
Coxiella burnetii, the agent of Q fever, is an obligate intracellular bacterium that has a tropism for cells of the mononuclear phagocyte system. Following internalization, C. burnetii remains in a phagosome that ultimately matures into a vacuole with lysosomal characteristics that supports pathogen replication. Most in vitro investigations of Coxiella –macrophage interactions have employed continuous cell lines. Although these studies have been informative, genetic alterations of immortalized cells may result in attenuated biological responses to infection relative to primary cells. Consequently, primary macrophages are preferred as in vitro model systems. Here, we describe procedures for propagation and isolation of C. burnetii from cell culture and the use of these preparations to infect primary macrophages derived from human peripheral blood monocytes. Both virulent phase I and avirulent phase II C. burnetii productively infect human monocyte-derived macrophages (MDMs) and replicate with approximately the same kinetics, thereby providing a more physiologically relevant in vitro model system to study the infectious process of this pathogen.
Key Words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Baca, O. G. and Paretsky, D. (1983) Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol Rev. 47, 127–149.
Babudieri, C. (1959) Q fever: a zoonosis. Adv. Vet. Sci. 5, 81–84.
Hilbink, F., Penrose, M., Kovacova, E., and Kazar, J. (1993) Q fever is absent from New Zealand. Int. J. Epidemiol. 22, 945–949.
Palmer, S. R. and Key, D. W. (1983) Placentitis and abortion in goats and sheep in Ontario caused by Coxiella burnetii. Can. Vet. J. 24, 60–63.
Maurin, M.and Raoult, D. (1999) Q fever. Clin. Microbiol. Rev. 12, 518–553.
Benenson, A. S. and Tigertt, W. D. (1956) Studies on Q fever in man. Trans. Assoc. Am. Physicians. 69, 98–104.
Moos, A. and Hackstadt, T. (1987) Comparative virulence of in tra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect. Immun. 55, 1144–1150.
Hatchette, T. F., Hudson, R. C., Schlech, W. F., Campbell, N. A., Hatchette, J. E., Ratnam, S., et al. (2001) Goat-associated Q fever: a new disease in Newfoundland. Emerg. Infect. Dis. 7, 413–419.
Heinzen, R. A., Scidmore, M.A., Rockey, D. D., and Hackstadt, T. (1996) Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect. Immun. 64, 796–809.
Ghigo, E., Honstettre, A., Capo, C., Gorvel, J. P., Raoult, D., and Mege, J. L. (2004) Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever. J. Infect. Dis. 190, 1767–1772.
Brennan, R. E., Russell, K., Zhang, G., and Samuel, J. E. (2004) Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect. Immun. 72, 6666–6675.
Miller, J. D., Curns, A. T., and Thompson, H.A. (2004) A growth study of Coxiella burnetii Nine Mile Phase I and Phase II in fibroblasts. FEMS Immunol. Med. Microbiol. 42, 291–297.
Weiss, E., Coolbaugh, J. C., and Williams, J. C. (1975) Separation of viable Rickettsia typhi from yolk sac and L cell host components by renografin density gradient centrifugation. Appl. Microbiol. 30, 456–463.
Samuel, J. E., Frazier, M.E., Kahn, M.L., Thomashow, L. S., and Mallavia, L. P. (1983) Isolation and characterization of a plasmid from phase I Coxiella burnetii. Infect. Immun. 41, 488–493.
Williams, J. C., Peacock, M.G., and McCaul, T. F. (1981) Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components. Infect. Immun. 32, 840–851.
Stein, A., Louveau, C., Lepidi, H., Ricci, F., Baylac, P., Davoust, B., et al. (2005) Q fever pneumonia: virulence of Coxiella burnetii pathovars in a murine model of aerosol infection. Infect. Immun. 73, 2469–2477.
Govorkova, E. A., Murti, G., Meignier, B., de Taisne, C., and Webster, R. G. (1996) African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J. Virol. 70, 5519–5524.
Burton, P. R., Stueckemann, J., Welsh, R. M., and Paretsky, D. (1978) Some ultrastructural effects of persistent infections by the rickettsia Coxiella burnetii in mouse L cells and green monkey kidney (Vero) cells. Infect. Immun. 21, 556–566.
Policastro, P. F., Peacock, M.G., and Hackstadt, T. (1996) Improved plaque assays for Rickettsia prowazekii in Vero 76 cells. J. Clin. Microbiol. 34, 1944–1948.
Coleman, S. A., Fischer, E. R., Howe, D., Mead, D. J., and Heinzen, R. A. (2004) Temporal analysis of Coxiella burnetii morphological differentiation. J. Bacteriol. 186, 7344–7352.
Zamboni, D. S. and Rabinovitch, M.(2003) Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages. Infect. Immun. 71, 1225–1233.
Beron, W., Gutierrez, M.G., Rabinovitch, M., and Colombo, M.I. (2002) Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics. Infect. Immun. 70, 5816–5821.
Meconi, S., Jacomo, V., Boquet, P., Raoult, D., Mege, J. L., and Capo, C. (1998) Coxiella burnetii induces reorganization of the actin cytoskeleton in human monocytes. Infect. Immun. 66, 5527–5533.
Baca, O. G., Roman, M.J., Glew, R. H., Christner, R. F., Buhler, J. E., and Aragon, A. S. (1993) Acid phosphatase activity in Coxiella burnetii: a possible virulence factor. Infect. Immun. 61, 4232–4239.
Veras, P. S., de Chastellier, C., Moreau, M.F., Villiers, V., Thibon, M., Mattei, D., et al. (1994) Fusion between large phagocytic vesicles: targeting of yeast and other particulates to phagolysosomes that shelter the bacterium Coxiella burnetii or the protozoan Leishmania amazonensis in Chinese hamster ovary cells. J. Cell Sci, 107, 3065–3076.
Baca, O. G., Akporiaye, E. T., Aragon, A. S., Martinez, I. L., Robles, M.V., and Warner, N. L. (1981) Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines. Infect. Immun. 33, 258–266.
Hackstadt, T. (1996) Biosafety concerns and Coxiella burnetii. Trends Microbiol. 4, 341–342.
Wiebe, M.E., Burton, P. R., and Shankel, D. M.(1972) Isolation and characterization of two cell types of Coxiella burnetii phase I. J. Bacteriol. 110, 368–377.
Acknowledgments
We thank Dale Howe and Diane Cockrell for critical review of this manuscript. This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Shannon, J.G., Heinzen, R.A. (2008). Infection of Human Monocyte-Derived Macrophages With Coxiella burnetii . In: DeLeo, F.R., Otto, M. (eds) Bacterial Pathogenesis. Methods in Molecular Biology™, vol 431. Humana Press. https://doi.org/10.1007/978-1-60327-032-8_15
Download citation
DOI: https://doi.org/10.1007/978-1-60327-032-8_15
Publisher Name: Humana Press
Print ISBN: 978-1-58829-740-2
Online ISBN: 978-1-60327-032-8
eBook Packages: Springer Protocols